Earnings History Data for BioNTech SE (BNTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioNTech SE

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2024	PM		BNTX	BioNTech SE	26,890	0.89	-1.26	0.73	BioNTech reports Q3 results, reconfirms FY guidance [11/4/2024 6:47 AM]	109.05	-2.44 (-2.18%)	113.00	1.52 (1.36%)	76.53 - 131.49	615,306	680,000	18,258
BioNTech reports Q3 results, reconfirms FY guidance [11/4/2024 6:47 AM] BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update [2024-11-04 06:45AM]
05-08-2024	PM		BNTX	BioNTech SE	19,180	-3.62	-2.16	-0.86	BioNTech GAAP EPS of -€3.36, revenue of €128.7M [8/5/2024 6:02 AM]	78.32	-3.69 (-4.50%)	76.95	-5.06 (-6.17%)	76.53 - 125.83	1,488,854	580,000	66,803
BioNTech GAAP EPS of -€3.36, revenue of €128.7M [8/5/2024 6:02 AM] Genmab stock slides 7% as BioNTech ends acasunlimab collaboration [8/5/2024 1:11 PM]
06-05-2024	PM		BNTX	BioNTech SE	21,930	-1.42	-0.61	2.20	BioNTech GAAP EPS of -€1.31, revenue of €187.6M [5/6/2024 7:03 AM]	93.19	0.47 (0.51%)	90.45	-2.27 (-2.45%)	85.21 - 125.83	882,787	440,000	83,580
BioNTech swings to quarterly net loss on massive decline in COVID shot revenue [5/6/2024 11:08 AM] BioNTech GAAP EPS of -€1.31, revenue of €187.6M [5/6/2024 7:03 AM]
20-03-2024	PM		BNTX	BioNTech SE	22,410	2.05	2.64	9.46	BioNTech reports Q4 results [3/20/2024 6:22 AM]	90.01	-4.11 (-4.37%)	88.72	-5.40 (-5.74%)	85.21 - 136.91	2,588,797	570,000	194,540
BioNTech reports Q4 results [3/20/2024 6:22 AM] Pfizer partner BioNTech ekes out Q4 profit despite 65% revenue drop [3/20/2024 7:05 AM]
06-11-2023	PM		BNTX	BioNTech SE	22,290	0.73	-0.58	7.04	BioNTech GAAP EPS of €0.67, revenue of €895.3M; updates FY23 guidance [11/6/2023 6:47 AM]	99.83	4.05 (4.23%)	101.48	5.70 (5.95%)	88.00 - 188.99	1,218,227	820,000	82,182
BioNTech GAAP EPS of €0.67, revenue of €895.3M; updates FY23 guidance [11/6/2023 6:47 AM] BioNTech cuts guidance as Q3 revenue falls 74% amid COVID cliff [11/6/2023 7:50 AM]
07-08-2023	PM		BNTX	BioNTech SE	25,700	-0.86	-0.75	7.31	BioNTech GAAP EPS of -€0.79, revenue of €167.7M; reaffirms FY23 COVID-19 vaccine revenue guidance [8/7/2023 6:04 AM]	98.49	-7.99 (-7.50%)	101.31	-5.17 (-4.86%)	95.50 - 188.99	2,996,910	630,000	114,565
BioNTech GAAP EPS of -€0.79, revenue of €167.7M; reaffirms FY23 COVID-19 vaccine revenue guidance [8/7/2023 6:04 AM] BioNTech reins in costs amid hit to COVID-driven sales boom [8/7/2023 7:01 AM]
08-05-2023	PM	6:00 AM ET (May 8)	BNTX	BioNTech SE	25,940	2.20	0.36	15.98	BioNTech beats Q1 top and bottom line estimates; reaffirms FY23 outlook [5/8/2023 6:47 AM]	107.94	-0.49 (-0.45%)	113.01	4.58 (4.22%)	106.64 - 188.99	1,098,181	700,000	42,003
BioNTech beats Q1 top and bottom line estimates; reaffirms FY23 outlook [5/8/2023 6:47 AM]
27-03-2023	PM	6:00 AM ET (Mar 27)	BNTX	BioNTech SE	32,670	9.46	8.68	13.93	BioNTech GAAP EPS of €9.26 beats by €1.51, revenue of €4.28B beats by €420M [3/27/2023 6:54 AM]	123.90	-4.30 (-3.35%)	122.43	-5.77 (-4.50%)	117.08 - 188.99	1,563,736	580,000	89,599
BioNTech GAAP EPS of €9.26 beats by €1.51, revenue of €4.28B beats by €420M [3/27/2023 6:54 AM] BioNTech projects €5B revenue from Pfizer-partnered COVID shot this year [3/27/2023 2:29 PM]
07-11-2022	PM	6:00 AM ET (Nov 7)	BNTX	BioNTech SE	35,250	7.04	3.66	14.56	BioNTech GAAP EPS of €6.98, revenue of €3.46B [11/7/2022 6:03 AM]	160.68	6.37 (4.13%)	152.19	-2.12 (-1.37%)	117.08 - 369.68	1,738,609	890,000	94,398
BioNTech GAAP EPS of €6.98, revenue of €3.46B [11/7/2022 6:03 AM] BioNTech dips as Q3 sales fall, raises lower end of revenue outlook as COVID boosters ship [11/7/2022 7:03 AM] Did Vaccine Stocks Just Get Their Last Boost? [Nov-04-22 06:17PM] Top Biotech Stocks for Q4 2022 [Nov-04-22 05:46PM] This Key Piece Of News Could Spark BioNTech, Moderna And Stoke Demand For Covid Boosters [Nov-04-22 04:20PM] UPDATE 1-Pfizer/BioNTech Omicron shot shows strong response after a month [Nov-04-22 12:10PM] Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day [Nov-04-22 11:21AM] China Agrees to Approve BioNTech's Covid-19 Vaccine for Foreigners, German Chancellor Says [Nov-04-22 11:11AM] BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market [Nov-04-22 10:41AM] UPDATE 2-German expats in China will have access to BioNTech vaccine, says Scholz [Nov-04-22 09:51AM] UPDATE 1-Germany's Scholz secures deal for expats in China to use BioNTech vaccine [Nov-04-22 09:51AM] Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity [Nov-04-22 09:43AM] Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shot [Nov-04-22 07:03AM] Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine [Nov-04-22 06:48AM] Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine [Nov-04-22 06:47AM] Pfizer/BioNTech Omicron booster shows strong response after a month [Nov-04-22 06:46AM] Coronavirus tally: New daily cases rise above 40,000 in U.S., China reportedly looks into easing COVID restrictions [Nov-04-22 06:40AM] BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreigners [Nov-04-22 06:23AM] Scholz secures agreement allowing expats in China to use BioNTech COVID-19 vaccine [Nov-04-22 06:22AM] BioNTech lifts lower end of vaccine sales target range [Nov-07-22 06:00AM] BioNTech Issues Bright Revenue Outlook. But The Stock Sinks After Profit Drop. [Nov-07-22 07:43AM] BioNTech Sees Some Vaccine Deliveries Shifting to Next Year [Nov-07-22 06:59AM] BioNTech profit and revenue fall sharply from year-ago period but top estimates [Nov-07-22 06:17AM] BioNTech Raises Covid Vaccine Sales Forecast as Boosters Ship [Nov-07-22 06:00AM] BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update [Nov-07-22 06:00AM]
08-08-2022	PM	6:00 AM ET (Aug 8)	BNTX	BioNTech SE	38,920	7.31	8.12	12.98	BioNTech GAAP EPS of €6.45 misses by €0.63, revenue of €3.2B misses by €910M [8/8/2022 6:04 AM]	168.94	-14.16 (-7.74%)	166.67	-16.44 (-8.98%)	117.08 - 457.93	3,188,318	920,000	217,011
BioNTech GAAP EPS of €6.45 misses by €0.63, revenue of €3.2B misses by €910M [8/8/2022 6:04 AM] BioNTech stock falls on Q2 miss as vaccine sales slump; eyes uptick in Q4 with Omicron shot delivery in October [8/8/2022 7:06 AM] Hot Stocks: DINO gains on Q2 results, MYOV rises on FDA news, BNTX sinks on earnings, and PLTR drops 14% [8/8/2022 8:30 AM] BioNTech expects Omicron-adapted vaccine deliveries as soon as October [Aug-08-22 06:00AM] BioNTech Announces Second Quarter Financial Results and Corporate Update [Aug-08-22 06:00AM] Amicus (FOLD) Q2 Earnings Beat, Galafold Sales Miss Estimates [Aug-05-22 11:55AM] Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children [Aug-05-22 10:30AM] Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates [Aug-05-22 09:57AM] Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx [Aug-05-22 09:45AM] BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates [Aug-05-22 06:45AM]
09-05-2022	PM	6:00 AM ET (May 9)	BNTX	BioNTech SE	35,030	15.98	9.14	5.29	BioNTech GAAP EPS of €14.24, revenue of $6.4B beats by €1.91B [5/9/2022 6:03 AM]	139.72	3.56 (2.61%)	137.80	1.63 (1.20%)	121.32 - 464.00	2,283,797	1,120,000	103,892
BioNTech GAAP EPS of €14.24, revenue of $6.4B beats by €1.91B [5/9/2022 6:03 AM] BioNTech stock rises as Q1 revenue triples Y/Y on the back of COVID-19 vaccine sales [5/9/2022 7:15 AM] COVID SCIENCE-Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from variants [May-06-22 01:13PM] FDA limits use of J&J COVID-19 vaccine over blood clot concerns [May-06-22 06:39AM] BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine [May-09-22 06:16AM] BioNTech earnings jump after 750 million COVID vaccines invoiced [May-09-22 06:15AM] BioNTech posts tripled Q1 vaccine sales but still flags full-year decline [May-09-22 06:11AM] BioNTech Announces First Quarter Financial Results and Corporate Update [May-09-22 06:01AM] BioNTech posts tripled Q1 vaccine sales but still flags full-year decline [May-09-22 06:00AM] UPDATE 1-BioNTech's Q1 vaccine sales triple but it still flags full-year decline [May-09-22 08:19AM] BioNTech's Q1 vaccine sales triple but it still flags full-year decline [May-09-22 06:11AM] BioNTech Pushes Toward Omicron-Adapted Booster as Sales Soar [May-09-22 06:45AM] BioNTech's Revenue Triples On Omicron Demand For Its Pfizer-Partnered Covid Shot [May-09-22 09:01AM] Rivian, Palantir, and Uber Fall Premarket; BioNTech, Coty Rise [May-09-22 03:45AM] BioNTech Clocks Over $6B In Q1 Sales, Sticks To FY22 Guidance [May-09-22 08:04AM] Why BioNTech Stock Climbed Today [May-09-22 02:53PM]
30-03-2022	PM	6:45 AM ET (Mar 30)	BNTX	BioNTech SE	40,340	13.93	8.02	1.87	BioNTech GAAP EPS of €12.18, revenue of €5.53B [3/30/2022 6:10 AM]	174.40	2.01 (1.17%)	183.89	11.50 (6.67%)	98.60 - 464.00	3,651,441	1,850,000	272,740
Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated) [3/29/2022 3:55 PM] BioNTech GAAP EPS of €12.18, revenue of €5.53B [3/30/2022 6:10 AM] BioNTech proposes €2.00 dividend, buyback of $1.5B [3/30/2022 6:38 AM] BioNTech Q4 profit soars on COVID vaccine sales; plans buyback, special dividend [3/30/2022 6:57 AM] Biden tells lawmakers to authorize billions in COVID spending [3/30/2022 4:21 PM] Why Moderna and BioNTech Were Winners Today [Mar-29-22 06:07PM] Coronavirus: FDA authorizes fourth COVID shots from Moderna and Pfizer [Mar-29-22 04:35PM] Moderna, BioNTech Pop After FDA OKs Another Covid Booster Round But Not For Everyone [Mar-29-22 04:13PM] UPDATE 3-U.S. authorizes second COVID booster for Americans 50 and older [Mar-29-22 11:44AM] U.S. FDA authorizes second COVID booster dose for people aged 50 and older [Mar-29-22 11:06AM] COVID-19: FDA authorizes another Pfizer, Moderna booster shot for Americans 50 and up [Mar-29-22 11:05AM] FDA green lights second booster of Pfizer/BioNTech, Moderna COVID shot for older Americans [Mar-29-22 11:02AM] FDA authorizes second booster of Pfizer/BioNTech COVID shot [Mar-29-22 10:39AM] Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older [Mar-29-22 10:30AM] BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:00AM] BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update [Mar-30-22 06:00AM] BioNTechs Earnings Top Estimates. It Plans a Buyback and Special Dividend. [Mar-30-22 06:16AM] BioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacks [Mar-30-22 06:43AM] UPDATE 1-BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:49AM] UPDATE 2-BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:49AM] Dow Jones Futures Today Dip Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 08:22AM] Coronavirus: FDA authorizes 4th COVID shots from Moderna and Pfizer [Mar-29-22 04:35PM] Dow Jones Futures Today Fall Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 08:34AM] BioNTech Stock Pops On Soaring Earnings, $1.5 Billion Share Buyback [Mar-30-22 09:00AM] Dow Jones Today Falls Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:35AM] BioNTech Soars on Q4 Beat, Special Dividend, Promise of Buyback [Mar-30-22 03:38AM] Dow Jones Today Firms Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:51AM] Dow Jones Firms Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:58AM] BioNTech: work on pan-variant COVID shots not yet ripe for clinical trials [Mar-30-22 09:19AM] Dow Jones Dips Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 10:24AM] Micron, Lululemon and BioNTech Rise Premarket; Five Below Falls [Mar-30-22 03:59AM] FDA Authorizes Pfizer, Moderna's Second COVID Booster Dose [Mar-30-22 09:18AM] Wall Street Opens Mostly Lower as Peace Hopes Damped; Dow Flat [Mar-30-22 05:52AM] Midday Stock Movers: Direct Digital, Lululemon Rally; Chewy Falls [Mar-30-22 07:42AM] CORRECTED-Pfizer/BioNTech COVID vaccine slashes pediatric hospitalization risk -U.S. study [Mar-30-22 05:00PM] Why These 10 Stocks Are on the Move on Wednesday [Mar-30-22 03:31PM] BioNTech SE (BNTX) Q4 2021 Earnings Call Transcript [Mar-30-22 08:00PM]
09-11-2021	PM	7:00 AM ET (Nov 9)	BNTX	BioNTech SE	66,440	14.56	11.79	-1.03	BioNTech EPS beats by $0.30; updates outlook for full year [11/9/2021 6:51 AM]	226.26	-16.34 (-6.74%)	251.95	9.35 (3.85%)	80.55 - 464.00	4,887,385	3,540,000	543,425
BioNTech Q3 2021 Earnings Preview [11/8/2021 2:51 PM] Pfizer eying broad COVID vaccine booster authorization as soon as this week -- WaPo [11/8/2021 12:12 PM] BioNTech EPS beats by $0.30; updates outlook for full year [11/9/2021 6:51 AM] BioNTech boosts outlook for COVID-19 vaccine revenue after earnings beat [11/9/2021 7:17 AM] Pfizer/BioNTech ask FDA to expand COVID-19 booster eligibility for all adults [11/9/2021 3:04 PM] Pfizer Stock Gaps Higher On Covid Pill Enthusiasm Is It A Buy Now? [Nov-08-21 01:51PM] Baron Funds: BioNTech (BNTX) has Potential to Disrupt the Biopharmaceutical Space [Nov-08-21 12:44PM] Why BioNTech Stock Is Bouncing Back Today [Nov-08-21 12:09PM] Is a Beat in Store for BioNTech (BNTX) This Earnings Season? [Nov-08-21 11:51AM] Is a Surprise Coming for BioNTech (BNTX) This Earnings Season? [Nov-08-21 08:17AM] BioNTechs Success Offers Antidote to EU Biopharma Skittishness [Nov-09-21 12:00AM] Could The Market Be Wrong About BioNTech SE (NASDAQ:BNTX) Given Its Attractive Financial Prospects? [Nov-09-21 05:04AM] BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update [Nov-09-21 06:45AM] BioNTech sees up to 17 billion eur in vaccine revenue this year [Nov-09-21 06:47AM] BioNTech Stock Is Getting a Lift. Earnings Were Strong. [Nov-09-21 08:44AM] BioNTech Expects Nearly $20 Billion In Covid Shot Sales; But Was The Guide High Enough? [Nov-09-21 08:59AM] Pfizer and BioNTech to seek backing for COVID-19 booster in all U.S. adults aged 18 and over, as deaths still average 1,200 a day [Nov-09-21 10:56AM] BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectations [Nov-09-21 11:12AM] Pfizer and BioNTech to seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day [Nov-09-21 10:56AM] Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day [Nov-09-21 03:20PM] Pfizer asks FDA to authorize COVID-19 booster shot for all adults [Nov-09-21 03:17PM] BioNTech SE (BNTX) Q3 2021 Earnings Call Transcript [Nov-09-21 07:31PM] Why BioNTech Is Tumbling Today [Nov-09-21 04:19PM] Pfizer, BioNTech Ask FDA to Expand Covid-19 Booster Use to All Adults [Nov-09-21 03:52PM] Pfizer Asking FDA To Approve Booster Shots For All Adults [Nov-09-21 11:48AM]
09-08-2021	PM	7:00 AM ET (Aug 9)	BNTX	BioNTech SE	97,800	12.98	8.35	-0.42	BioNTech beats on revenue; issues full year guidance [8/9/2021 7:09 AM]	446.24	57.23 (14.71%)	409.23	20.22 (5.20%)	54.10 - 459.88	11,426,252	5,720,000	419,431
Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey [8/9/2021 2:04 AM] Fauci favors speeding COVID-19 booster shots for vulnerable individuals [8/9/2021 6:55 AM] BioNTech beats on revenue; issues full year guidance [8/9/2021 7:09 AM] BioNTech raises projection for COVID-19 vaccine sales after delivering one billion doses [8/9/2021 8:51 AM] Dow Jones Futures: Market Rally Hits Highs As Apple, Tesla, Square Lead 6 Stocks Near Buy Points; What To Do Now [Aug-06-21 05:50PM] Novavax CEO explains delay in COVID-19 vaccine EUA filing [Aug-06-21 03:31PM] Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected [Aug-06-21 06:08AM] Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week [Aug-06-21 05:58AM] BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update [Aug-09-21 07:00AM] BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far [Aug-09-21 07:00AM] UPDATE 1-BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far [Aug-09-21 08:01AM] BioNTech says has supplied more than 1 billion COVID-19 vaccine doses so far [Aug-09-21 08:09AM] Dow Jones Today, Futures, Global Markets Mixed As Oil Slides; Tesla Upgraded, BioNTech Rallies On Q2 Blowout [Aug-09-21 08:11AM] BioNTech Stock Pops On Massive Earnings Beat; Company Looks Beyond Covid [Aug-09-21 09:03AM] Dow Jones Today, Stocks Mixed As Oil Slides; Tesla Upgraded, BioNTech Rallies On Q2 Blowout [Aug-09-21 09:45AM] BioNTech Stock Climbs. Earnings Blew Past Expectations. [Aug-09-21 10:41AM] The Messenger RNA Vaccine Stocks Are the Best Investment Against COVID [Aug-09-21 06:45AM] BioNTech Stock Pops On Earnings Crush, Plans To Deliver 2.2 Billion Doses [Aug-09-21 09:03AM] BioNTech says vaccine repeats beat devising new one for now [Aug-09-21 08:09AM] UPDATE 2-BioNTech says vaccine repeats beat devising new one for now [Aug-09-21 08:01AM] BioNTech Soars As It Says Its Developing Updated Covid Shot For Delta [Aug-09-21 07:06AM] BioNTech Stock Jumps as COVID Vaccine Lifts Profit Past Estimates [Aug-09-21 08:09AM] Dow Jones Slips From Record High, Nasdaq Rises As Covid-19 Stocks Soar [Aug-09-21 12:31PM] Dow Jones Slips But Nasdaq Advances As These Covid Stocks Hit New Highs [Aug-09-21 01:43PM] COVID-19: In schools we should start at least implementing a testing requirement, doctor says [Aug-09-21 02:16PM] Vaccine stocks rally, DraftKings to buy Golden Nugget, Bitcoins weekend moves [Aug-09-21 02:47PM] Pfizer Expects $33.5 Billion In Full-Year Covid Vaccine Sales Is PFE Stock A Buy? [Aug-09-21 03:22PM] Why Moderna, BioNTech, and Novavax Stock Soared Today [Aug-09-21 05:54PM] COVID SCIENCE-Moderna may be superior to Pfizer against Delta; breakthrough odds rise with time [Aug-09-21 04:36PM] BioNTech SE (BNTX) Q2 2021 Earnings Call Transcript [Aug-09-21 08:30PM]
10-05-2021	PM	6:30 AM ET (May 10)	BNTX	BioNTech SE	40,580	5.29	4.31	-0.26	BioNTech EPS beats by €1.33, beats on revenue [5/10/2021 7:03 AM]	202.49	18.78 (10.22%)	200.20	16.49 (8.98%)	45.08 - 213.15	6,619,873	5,360,000	421,507
BioNTech EPS beats by €1.33, beats on revenue [5/10/2021 7:03 AM] BioNTech trades higher after raising 2021 guidance for COVID-19 vaccine sales [5/10/2021 7:44 AM] Pfizer/ BioNTech vaccine's protection against COVID-related deaths rises up to 97% after both doses: new study [5/10/2021 12:15 PM] World Health Organization names India COVID-19 variant as a global concern [5/10/2021 12:40 PM] FDA to hold AdCom meeting to discuss expanding COVID-19 vaccine use in children [5/10/2021 1:12 PM] Dubai Business Improves; BioNTechs Singapore Site: Virus Update [May-10-21 02:43AM] UPDATE 2-BioNTech to build mRNA manufacturing site in Singapore [May-10-21 02:22AM] BioNTech to build mRNA manufacturing site in Singapore [May-10-21 01:56AM] BioNTech to build mRNA manufacturing site in Singapore [May-10-21 01:48AM] BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore [May-10-21 01:31AM] BioNTech Chooses Singapore; Delhi Extends Lockdown: Virus Update [May-10-21 05:29AM] UPDATE 3-BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 02:22AM] BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 01:56AM] BioNTech SE - ADR to Host Earnings Call [May-10-21 06:15AM] BioNTech Announces First Quarter 2021 Financial Results and Corporate Update [May-10-21 07:00AM] BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year [May-10-21 07:16AM] UPDATE 4-BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 02:22AM] BioNTech Earnings Easily Beat, Covid Vaccine Maker Announces Asia Expansion; Stock Jumps [May-10-21 07:19AM] BioNTech shares soar 8% as COVID-19 vaccines drive revenue surge [May-10-21 07:45AM] Premarket Movers Monday - BioNTech, FireEye, Freeport-McMoRan, AMC [May-10-21 04:05AM] Dow Jones Today Gains, Nasdaq Futures Lag As Commodities Rally; Freeport Jumps, BioNTech Spikes On Asia Deal [May-10-21 08:13AM] BioNTech Sees Sales Boost; U.K. Lowers Alert Level: Virus Update [May-10-21 08:45AM] UPDATE 1-BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year [May-10-21 08:49AM] BioNTech shares soar 8% in premarket as COVID-19 vaccines help revenues smash estimates [May-10-21 09:00AM] BioNTech Delivers Blowout Q1 Results [May-10-21 09:25AM] BioNTech To Set Up Manufacturing Plant In Singapore [May-10-21 09:21AM] Dow Jones Today Rides Commodities Rally To New High, Nasdaq Lags; Freeport Jumps, BioNTech Spikes On Asia Deal [May-10-21 09:40AM] BioNTech Stock Jumps As It Plans New mRNA Manufacturing Facility In Singapore By 2023 [May-10-21 06:45AM] U.S. Cases Hit 8-Month Low; U.K. Eases Alert Level: Virus Update [May-10-21 10:25AM] When Will Adolescents Be Eligible for a Coronavirus Vaccine? [May-10-21 10:21AM] Dow Jones Rallies, Tech Stocks Dive As Covid Vaccine Maker Surges On Earnings; Apple, Tesla Sell Off [May-10-21 10:12AM] What BioNTechs Earnings Mean for the Drug Makers [May-10-21 10:12AM] Dow Jones Rallies 300 Points To Extend Win Streak; Nasdaq Drops As Tech Stocks Weigh [May-10-21 12:23PM] UPDATE 1-One AZ COVID-19 vaccine dose gives 80% lower death risk - English data [May-10-21 11:07AM] Indias COVID crisis deepens, as BioNTech says theres no evidence its vaccine needs adapting to cope with new variants [May-10-21 10:51AM] BioNTech shares soar 7% as COVID-19 vaccines help revenues smash estimates [May-10-21 08:59AM] BioNTech Stock Pops On Quadruple-Digit Sales Growth Amid Asia Expansion [May-10-21 11:01AM] COVID-19 is not at the point yet where we can have mass gatherings: Doctor [May-10-21 01:53PM] How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree [May-10-21 06:04PM] FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update [May-10-21 05:27PM] FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15 [May-10-21 05:24PM] U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15 [May-10-21 05:23PM] U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15 [May-10-21 05:14PM] BioNTechs Covid-19 Vaccine Success Sparks Investments in German Biotech [May-10-21 11:58AM] US drugs regulator authorises BioNTech/Pfizer Covid vaccine for under-16s [May-10-21 08:00PM] UPDATE 2-U.S. children ages 12 to 15 could begin COVID-19 vaccinations Thursday [May-10-21 05:23PM]
30-03-2021	PM	7:15 AM ET (Mar 30)	BNTX	BioNTech SE	23,060	1.87	-0.56	-0.29	BioNTech EPS beats by €1.67, beats on revenue [3/30/2021 6:37 AM]	104.84	8.93 (9.31%)	99.60	3.69 (3.85%)	37.00 - 131.00	3,204,686	1,150,000	121,263
BioNTech Q4 2020 Earnings Preview [3/29/2021 2:27 PM] Pfizer/ BioNTech and Moderna vaccines are 80% effective in preventing COVID-19 infections after single dose [3/29/2021 11:45 AM] BioNTech COVID-19 vaccines delivered to Hong Kong are safe, an initial investigation finds [3/29/2021 11:12 AM] BioNTech EPS beats by €1.67, beats on revenue [3/30/2021 6:37 AM] BioNTech rises after earnings beat; raises 2021 manufacturing capacity [3/30/2021 7:25 AM] CDC Head Expresses Sense Of 'Impending Doom' Despite New Vaccine Study [Mar-29-21 04:20PM] Space ETF, BioNTech, Chewy Profits: 3 Things to Watch [Mar-29-21 11:47AM] Pfizer, Moderna Vaccines Prevent COVID-19; CDC Warns of 'Doom' [Mar-29-21 09:22AM] Pound pushes higher on vaccine optimism and reopening of UK economy [Mar-29-21 09:07AM] Taiwan says no progress in BioNTech vaccine talks [Mar-29-21 02:35AM] AstraZeneca woes continue as Canada suspends its jab for over-55s [Mar-30-21 05:56AM] BioNTech SE - ADR to Host Earnings Call [Mar-30-21 06:15AM] BioNTech Announces Full Year 2020 Financial Results and Corporate Update [Mar-30-21 06:30AM] BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 06:37AM] UPDATE 1-BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 07:15AM] BioNTech Expects $11.5 Billion in Covid-19 Vaccine Revenue [Mar-30-21 07:58AM] New COVID strain detected in Israel; Pfizer vaccine purchase bid delayed [Mar-30-21 08:47AM] BioNTech increases Covid vaccine production target to 2.5bn doses [Mar-29-21 08:00PM] UPDATE 2-BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 07:15AM] AstraZeneca woes continue as Berlin, Canada suspend jab [Mar-30-21 05:56AM] BioNTech owners in talks to invest in German cancer labs group -sources [Mar-30-21 09:22AM] BioNTech's Q4 Results Wowed but Were Just the Tip of the Iceberg [Mar-30-21 10:00AM] BioNTech Stock Pops As Company Projects $11.5 Billion In Covid Vaccine Sales [Mar-30-21 09:50AM] BioNTech and Pfizer Boost 2021 Vaccine Target to 2.5B Doses [Mar-30-21 05:47AM] Biotech emerges as 'superhero' of global pandemic [Mar-30-21 10:40AM] Why the COVID superhero villain tug-of-war will be an eternal battle [Mar-30-21 10:44AM] Why BioNTech Stock Is Jumping Today [Mar-30-21 11:39AM] 5 Top Stock Gainers for Tuesday: Yelp, BioNTech, McCormick [Mar-30-21 08:10AM] BioNTech Stock Is Trading Higher On First Annual Profit; Raises 2021 Production Target For COVID-19 Shots To 2.5B Doses [Mar-30-21 09:36AM] We can vaccinate our way out of this phase of the pandemic: Doctor [Mar-30-21 01:27PM] BioNTech Jumps After Raising Its Covid Vaccine Goal to 2.5 Billion Doses [Mar-30-21 09:03AM] 5 Top Stock Gainers for Tuesday: Yelp, BioNTech, General Motors [Mar-30-21 12:39PM]
10-11-2020	PM	6:00 AM ET (Nov 10)	BNTX	BioNTech SE	21,910	-1.03	-0.46	-0.16	BioNTech EPS misses by €0.50, beats on revenue [11/10/2020 7:19 AM]	112.75	7.95 (7.59%)	110.08	5.28 (5.04%)	17.07 - 115.00	6,927,712	3,141,858	913,552

11-08-2020	PM	8:05 AM ET (Aug 11)	BNTX	BioNTech SE	18,340	-0.42	-0.29	0.00	BioNTech EPS misses by $0.28, misses on revenue [8/11/2020 6:09 AM]	72.36	-1.60 (-2.16%)	69.20	-4.75 (-6.42%)	12.52 - 105.00	2,547,133	3,287,496	170,475

12-05-2020	PM	6:40 AM ET (May 12)	BNTX	BioNTech SE	11,170	-0.26	-0.30	0.00	BioNTech EPS beats by €0.01, beats on revenue [5/12/2020 8:14 AM]	49.33	-0.65 (-1.30%)	49.31	-0.02 (-0.04%)	12.52 - 105.00	1,822,879	1,286,757	4,965